WC
Woodstock Corp Portfolio holdings
AUM
$1.09B
This Quarter Return
+9.7%
1 Year Return
+20.65%
3 Year Return
+97.37%
5 Year Return
+175.97%
10 Year Return
+415.12%
AUM
$864M
AUM Growth
+$864M
(+8.3%)
Cap. Flow
-$3.42M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
36.02%
Holding
173
New
5
Increased
47
Reduced
70
Closed
7
Top Buys
| 1 |
DexCom
DXCM
|
$1.24M |
| 2 |
Fortinet
FTNT
|
$562K |
| 3 |
EyePoint Pharmaceuticals
EYPT
|
$514K |
| 4 |
Abbott
ABT
|
$465K |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$385K |
Top Sells
| 1 |
Verizon
VZ
|
$1.2M |
| 2 |
Bristol-Myers Squibb
BMY
|
$870K |
| 3 |
Microsoft
MSFT
|
$561K |
| 4 |
CVS Health
CVS
|
$534K |
| 5 |
Silicom
SILC
|
$447K |
Sector Composition
| 1 | Technology | 28.38% |
| 2 | Healthcare | 19.95% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Industrials | 7.64% |
| 5 | Consumer Staples | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
SPDR S&P MidCap 400 ETF Trust
MDY
$23.5B
| $2.28M | 0.26% |
4,487
| – | – |
|
77
GE Aerospace
GE
$291B
| $2.27M | 0.26% |
17,816
-88
| -0.5% | -$11.2K |
|
78
Enbridge
ENB
$105B
| $2.19M | 0.25% |
60,879
-96
| -0.2% | -$3.46K |
|
79
Ligand Pharmaceuticals
LGND
$3.23B
| $2.15M | 0.25% |
30,111
-4,049
| -12% | -$289K |
|
|
80
Verizon
VZ
$183B
| $2M | 0.23% |
53,078
-31,801
| -37% | -$1.2M |
|
81
Lincoln National
LNC
$8.15B
| $1.9M | 0.22% |
70,293
+11,639
| +20% | +$314K |
|
82
General Dynamics
GD
$86.5B
| $1.88M | 0.22% |
7,226
+120
| +2% | +$31.2K |
|
83
Colgate-Palmolive
CL
$67.5B
| $1.77M | 0.2% |
22,170
-1,072
| -5% | -$85.4K |
|
84
Sherwin-Williams
SHW
$90.5B
| $1.72M | 0.2% |
5,512
+166
| +3% | +$51.8K |
|
85
Kimberly-Clark
KMB
$42.4B
| $1.7M | 0.2% |
14,031
+47
| +0.3% | +$5.71K |
|
86
Vertex Pharmaceuticals
VRTX
$101B
| $1.7M | 0.2% |
4,177
| – | – |
|
87
iShares Core High Dividend ETF
HDV
$11.5B
| $1.65M | 0.19% |
16,180
| – | – |
|
88
Bank of New York Mellon
BK
$73.4B
| $1.55M | 0.18% |
29,762
| – | – |
|
89
iShares Core S&P Small-Cap ETF
IJR
$84.2B
| $1.5M | 0.17% |
13,836
-1
| -0% | -$108 |
|
90
Carrier Global
CARR
$52.9B
| $1.4M | 0.16% |
24,447
-855
| -3% | -$49.1K |
|
91
Neurocrine Biosciences
NBIX
$13.7B
| $1.34M | 0.16% |
10,179
| – | – |
|
92
Southern Company
SO
$101B
| $1.3M | 0.15% |
18,560
+472
| +3% | +$33.1K |
|
93
Akamai
AKAM
$11.1B
| $1.22M | 0.14% |
10,295
| – | – |
|
94
American Express
AXP
$225B
| $1.21M | 0.14% |
6,448
-850
| -12% | -$159K |
|
95
Otis Worldwide
OTIS
$33.6B
| $1.19M | 0.14% |
13,251
-507
| -4% | -$45.4K |
|
96
Schlumberger
SLB
$52.4B
| $1.16M | 0.13% |
22,291
| – | – |
|
97
Varonis Systems
VRNS
$6.14B
| $1.16M | 0.13% |
25,612
| – | – |
|
98
Insperity
NSP
$2.07B
| $970K | 0.11% |
8,274
| – | – |
|
99
Shopify
SHOP
$182B
| $918K | 0.11% |
11,790
| – | – |
|
100
Vanguard FTSE Developed Markets ETF
VEA
$169B
| $854K | 0.1% |
17,824
| – | – |
|